Zoetis Inc. Unrecognized Tax Benefits, Interest on Income Taxes Expense
Zoetis Inc. (ZTS) reported Unrecognized Tax Benefits, Interest on Income Taxes Expense of $14.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-12.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense · last filed 2026-02-12
- Zoetis Inc. unrecognized tax benefits, interest on income taxes expense for fiscal 2025 was $14.00M, a 16.67% increase from fiscal 2024.
- Zoetis Inc. unrecognized tax benefits, interest on income taxes expense for fiscal 2024 was $12.00M, a 20.00% increase from fiscal 2023.
- Zoetis Inc. unrecognized tax benefits, interest on income taxes expense for fiscal 2023 was $10.00M, a 150.00% increase from fiscal 2022.
- Zoetis Inc. unrecognized tax benefits, interest on income taxes expense for fiscal 2022 was $4.00M, a 300.00% increase from fiscal 2021.
| Period end | Unrecognized Tax Benefits, Interest on Income Taxes Expense 12 month |
|---|---|
| 2025-12-31 | $14.00M 10-K · filed 2026-02-12 |
| 2024-12-31 | $12.00M 10-K · filed 2026-02-12 |
| 2023-12-31 | $10.00M 10-K · filed 2026-02-12 |
| 2022-12-31 | $4.00M 10-K · filed 2025-02-13 |
| 2021-12-31 | $1.00M 10-K · filed 2024-02-13 |
| 2020-12-31 | $2.00M 10-K · filed 2023-02-14 |
| 2019-12-31 | $2.00M 10-K · filed 2022-02-15 |
| 2018-12-31 | $1.00M 10-K · filed 2021-02-16 |
| 2017-12-31 | $1.00M 10-K · filed 2020-02-13 |
| 2016-12-31 | $2.00M 10-K · filed 2019-02-14 |
| 2015-12-31 | $1.00M 10-K · filed 2018-02-15 |
| 2014-12-31 | $1.00M 10-K · filed 2017-02-16 |
| 2013-12-31 | $3.00M 10-K · filed 2016-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |